The 340B Drug Pricing Program

The 340B Drug Pricing Program PDF Author: Felix C. Larsen
Publisher: Nova Snova
ISBN: 9781536179040
Category :
Languages : en
Pages : 340

Get Book Here

Book Description
The 340B Drug Pricing Program (340B Program) and the Medicaid Drug Rebate Program require manufacturers to provide discounts on outpatient drugs in order to have their drugs covered by Medicaid. These discounts take the form of reduced sales prices for covered entities participating in the 340B Program--eligible hospitals and federal grantees--and rebates on drugs dispensed to Medicaid beneficiaries, shared by states and the federal government. This book looks at important issues pertaining to the 340B Drug Pricing Program.

The 340B Drug Pricing Program

The 340B Drug Pricing Program PDF Author: Felix C. Larsen
Publisher: Nova Snova
ISBN: 9781536179040
Category :
Languages : en
Pages : 340

Get Book Here

Book Description
The 340B Drug Pricing Program (340B Program) and the Medicaid Drug Rebate Program require manufacturers to provide discounts on outpatient drugs in order to have their drugs covered by Medicaid. These discounts take the form of reduced sales prices for covered entities participating in the 340B Program--eligible hospitals and federal grantees--and rebates on drugs dispensed to Medicaid beneficiaries, shared by states and the federal government. This book looks at important issues pertaining to the 340B Drug Pricing Program.

Making Medicines Affordable

Making Medicines Affordable PDF Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235

Get Book Here

Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Delivering Affordable Cancer Care in the 21st Century

Delivering Affordable Cancer Care in the 21st Century PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 030926944X
Category : Medical
Languages : en
Pages : 95

Get Book Here

Book Description
Rising health care costs are a central fiscal challenge confronting the United States. National spending on health care currently accounts for 18 percent of gross domestic product (GDP), but is anticipated to increase to 25 percent of GDP by 2037. The Bipartisan Policy Center argues that "this rapid growth in health expenditures creates an unsustainable burden on America's economy, with far-reaching consequences". These consequences include crowding out many national priorities, including investments in education, infrastructure, and research; stagnation of employee wages; and decreased international competitiveness.In spite of health care costs that far exceed those of other countries, health outcomes in the United States are not considerably better. With the goal of ensuring that patients have access to high-quality, affordable cancer care, the Institute of Medicine's (IOM's) National Cancer Policy Forum convened a public workshop, Delivering Affordable Cancer Care in the 21st Century, October 8-9, 2012, in Washington, DC. Delivering Affordable Cancer Care in the 21st Century summarizes the workshop.

Complete Healthcare Compliance Manual 2021

Complete Healthcare Compliance Manual 2021 PDF Author:
Publisher:
ISBN: 9781733598750
Category :
Languages : en
Pages :

Get Book Here

Book Description


The Chargemaster Essentials Toolkit

The Chargemaster Essentials Toolkit PDF Author: Valerie A. Rinkle
Publisher: Hcpro, a Division of Simplify Compliance
ISBN: 9781683080862
Category : Health insurance claims
Languages : en
Pages : 0

Get Book Here

Book Description


Sexually Transmitted Infections

Sexually Transmitted Infections PDF Author: National Academies of Sciences, Engineering, and Medicine
Publisher:
ISBN: 9780309683951
Category : Medical
Languages : en
Pages : 750

Get Book Here

Book Description
One in five people in the United States had a sexually transmitted infection (STI) on any given day in 2018, totaling nearly 68 million estimated infections. STIs are often asymptomatic (especially in women) and are therefore often undiagnosed and unreported. Untreated STIs can have severe health consequences, including chronic pelvic pain, infertility, miscarriage or newborn death, and increased risk of HIV infection, genital and oral cancers, neurological and rheumatological effects. In light of this, the Centers for Disease Control and Prevention, through the National Association of County and City Health Officials, commissioned the National Academies of Sciences, Engineering, and Medicine to convene a committee to examine the prevention and control of sexually transmitted infections in the United States and provide recommendations for action. In 1997, the Institute of Medicine released a report, The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Although significant scientific advances have been made since that time, many of the problems and barriers described in that report persist today; STIs remain an underfunded and comparatively neglected field of public health practice and research. The committee reviewed the current state of STIs in the United States, and the resulting report, Sexually Transmitted Infections: Advancing a Sexual Health Paradigm, provides advice on future public health programs, policy, and research.

Healthcare Money Campfire Stories

Healthcare Money Campfire Stories PDF Author: Eric Bricker
Publisher:
ISBN: 9781703360714
Category :
Languages : en
Pages : 129

Get Book Here

Book Description
Learn 16 Ways Money Influences Healthcare and the Practice of Medicine That You Have Never Seen Before. 'Healthcare Money Campfire Stories' is based on the true experiences of Dr. Eric Bricker. Dr. Bricker is an internal medicine physician and former Co-Founder and Chief Medical Officer of Compass Professional Health Services. Compass is a Healthcare Navigation service that grew to 2,000+ clients including T-Mobile, Southwest Airlines and Chili's/Maggiano's Restaurants. Compass was acquired by Alight Solutions in July 2018. Alight is a 10,000 person employee benefits and HR outsourcing company that separated from Aon in 2017. In 'Healthcare Money Campfire Stories' you will learn 1) the physician hierarchy based on pay and lifestyle, 2) how hospitals spread financial risk just like insurance companies and 3) the key to a correct diagnosis and treatment plan--and lower cost healthcare. 'Healthcare Money Campfire Stories' teaches these three lessons along with 13 more through a series of stories that are short, suspenseful and sometimes funny... just like a campfire story.

Pharmacy Management

Pharmacy Management PDF Author: Shane P. Desselle
Publisher: McGraw Hill Professional
ISBN: 9780071418690
Category : Medical
Languages : en
Pages : 628

Get Book Here

Book Description
Editors Desselle and Zgarrick have brought together 33 contributed chapters in their endeavor to prepare pharmacy students for the realities of managing a practice. After a section on why it's important to study management in pharmacy school, coverage includes the various ins-and-outs of managing oneself (understanding stress), operations, people,

Examining the 340B Drug Pricing Program

Examining the 340B Drug Pricing Program PDF Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Publisher:
ISBN:
Category : Older people
Languages : en
Pages : 112

Get Book Here

Book Description


Drug Pricing

Drug Pricing PDF Author: Debra A. Draper
Publisher:
ISBN: 9781437989878
Category :
Languages : en
Pages :

Get Book Here

Book Description
The Health Resources and Services Admin. (HRSA) oversees the 340B Drug Pricing Program, through which participating drug manufacturers give certain entities within the health care safety net -- known as covered entities (CE) -- access to discounted prices on outpatient drugs. CE include specified fed. grantees and hospitals. The number of CE sites has nearly doubled in the past 10 years to over 16,500. This study examines: (1) the extent to which CE generate 340B revenue, factors that affect revenue generation, and how they use the program; (2) how manufacturers' dist. of drugs at 340B prices affects CE or non-340B providers' access to drugs; and (3) HRSA's oversight of the 340B program. Charts and tables. A print on demand report.